Mechanisms of impaired regulation by CD4+CD25+FOXP3+ regulatory T cells in human autoimmune diseases (original) (raw)

• Ochs, H. D., Gambineri, E. & Torgerson, T. R. IPEX, FOXP3 and regulatory T-cells: a model for autoimmunity. Immunol. Res. 38, 112–121 (2007).
  Article CAS PubMed Google Scholar
• Brunkow, M. E. et al. Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nature Genet. 27, 68–73 (2001).
  Article CAS PubMed Google Scholar
• Sakaguchi, S. et al. Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease. Immunol. Rev. 212, 8–27 (2006).
  Article CAS PubMed Google Scholar
• Baecher-Allan, C. et al. CD4+CD25high regulatory cells in human peripheral blood. J. Immunol. 167, 1245–1253 (2001). One of the first papers to describe human CD4+CD25+ T Reg cells and to investigate their function.
  Article CAS PubMed Google Scholar
• Stephens, L. A. et al. Human CD4+CD25+ thymocytes and peripheral T cells have immune suppressive activity in vitro. Eur. J. Immunol. 31, 1247–1254 (2001).
  Article CAS PubMed Google Scholar
• Taams, L. S. et al. Antigen-specific T cell suppression by human CD4+CD25+ regulatory T cells. Eur. J. Immunol. 32, 1621–1630 (2002). This paper describes the antigen-specific nature of human T Reg cells.
  Article CAS PubMed Google Scholar
• Jiang, S. et al. Regulatory T cells and transplantation tolerance. Hum. Immunol. 67, 765–776 (2006).
  Article CAS PubMed Google Scholar
• Sakaguchi, S. et al. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor α-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol. 155, 1151–1164 (1995). This paper describes the ability of CD4+CD25+ T cells to suppress autoimmune disease.
  CAS PubMed Google Scholar
• Tang, Q. et al. _In vitro_-expanded antigen-specific regulatory T cells suppress autoimmune diabetes. J. Exp. Med. 199, 1455–1465 (2004). This paper shows the enhanced ability of antigen-specific T Reg cells to cure diabetes in mice.
  Article CAS PubMed PubMed Central Google Scholar
• Mottet, C., Uhlig, H. H. & Powrie, F. Cutting edge: cure of colitis by CD4+CD25+ regulatory T cells. J. Immunol. 170, 3939–3943 (2003). This paper shows that T Reg cells can cure colitis in a mouse model.
  Article CAS PubMed Google Scholar
• Liston, A. & Rudensky, A. Y. Thymic development and peripheral homeostasis of regulatory T cells. Curr. Opin. Immunol. 19, 176–185 (2007).
  Article CAS PubMed Google Scholar
• Darrasse-Jeze, G. et al. Feedback control of regulatory T cell homeostasis by dendritic cells in vivo. J. Exp. Med. 206, 1853–1862 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Wildin, R. S., Smyk-Pearson, S. & Filipovich, A. H. Clinical and molecular features of the immunodysregulation, polyendocrinopathy, enteropathy, X linked (IPEX) syndrome. J. Med. Genet. 39, 537–545 (2002). This paper describes the syndrome IPEX and its relationship to loss of FOXP3 expression.
  Article CAS PubMed PubMed Central Google Scholar
• Hori, S., Nomura, T. & Sakaguchi, S. Control of regulatory T cell development by the transcription factor Foxp3. Science 299, 1057–1061 (2003).
  Article CAS PubMed Google Scholar
• Fontenot, J. D., Gavin, M. A. & Rudensky, A. Y. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nature Immunol. 4, 330–336 (2003).
  Article CAS Google Scholar
• Walker, M. R. et al. Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+CD25− T cells. J. Clin. Invest. 112, 1437–1443 (2003).
  Article CAS PubMed Google Scholar
• Liu, W. et al. CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells. J. Exp. Med. 203, 1701–1711 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Sakaguchi, S. et al. FOXP3+ regulatory T cells in the human immune system. Nature Rev. Immunol. 10, 490–500 (2010).
  Article CAS Google Scholar
• Floess, S. et al. Epigenetic control of the foxp3 locus in regulatory T cells. PLoS Biol. 5, e38 (2007).
  Article PubMed PubMed Central CAS Google Scholar
• Thornton, A. M. et al. Expression of Helios, an Ikaros transcription factor family member, differentiates thymic-derived from peripherally induced Foxp3+ T regulatory cells. J. Immunol. 184, 3433–3441 (2010).
  Article CAS PubMed Google Scholar
• Miyara, M. et al. Functional delineation and differentiation dynamics of human CD4+ T cells expressing the FoxP3 transcription factor. Immunity 30, 899–911 (2009). This paper refines our understanding of the subsets of CD4+FOXP3+ T cells, and has important implications with respect to the suppressive and proliferative capacity of T Reg cells.
  Article CAS PubMed Google Scholar
• Vignali, D. A., Collison, L. W. & Workman, C. J. How regulatory T cells work. Nature Rev. Immunol. 8, 523–532 (2008).
  Article CAS Google Scholar
• Bluestone, J. A. & Boehmer, H. Regulatory T cells. Semin. Immunol. 18, 77 (2006).
  Article Google Scholar
• Workman, C. J. et al. The development and function of regulatory T cells. Cell. Mol. Life Sci. 66, 2603–2622 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Gregori, S. et al. Dynamics of pathogenic and suppressor T cells in autoimmune diabetes development. J. Immunol. 171, 4040–4047 (2003).
  Article CAS PubMed Google Scholar
• You, S. et al. Autoimmune diabetes onset results from qualitative rather than quantitative age-dependent changes in pathogenic T-cells. Diabetes 54, 1415–1422 (2005).
  Article CAS PubMed Google Scholar
• D'Alise, A. M. et al. The defect in T-cell regulation in NOD mice is an effect on the T-cell effectors. Proc. Natl Acad. Sci. USA 105, 19857–19862 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Clough, L. E. et al. Release from regulatory T cell-mediated suppression during the onset of tissue-specific autoimmunity is associated with elevated IL-21. J. Immunol. 180, 5393–5401 (2008).
  Article CAS PubMed Google Scholar
• Korn, T. et al. Myelin-specific regulatory T cells accumulate in the CNS but fail to control autoimmune inflammation. Nature Med. 13, 423–431 (2007).
  Article CAS PubMed Google Scholar
• Monk, C. R. et al. MRL/Mp CD4+, CD25− T cells show reduced sensitivity to suppression by CD4+, CD25+ regulatory T cells in vitro: a novel defect of T cell regulation in systemic lupus erythematosus. Arthritis Rheum. 52, 1180–1184 (2005).
  Article CAS PubMed Google Scholar
• Walker, L. S. Regulatory T cells overturned: the effectors fight back. Immunology 126, 466–474 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Tang, Q. et al. Central role of defective interleukin-2 production in the triggering of islet autoimmune destruction. Immunity 28, 687–697 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Kukreja, A. et al. Multiple immuno-regulatory defects in type-1 diabetes. J. Clin. Invest. 109, 131–140 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Putnam, A. L. et al. CD4+CD25high regulatory T cells in human autoimmune diabetes. J. Autoimmun. 24, 55–62 (2005).
  Article CAS PubMed Google Scholar
• Brusko, T. et al. No alterations in the frequency of FOXP3+ regulatory T-cells in type 1 diabetes. Diabetes 56, 604–612 (2007).
  Article CAS PubMed Google Scholar
• Brusko, T. M. et al. Functional defects and the influence of age on the frequency of CD4+ CD25+ T-cells in type 1 diabetes. Diabetes 54, 1407–1414 (2005).
  Article CAS PubMed Google Scholar
• Lindley, S. et al. Defective suppressor function in CD4+CD25+ T-cells from patients with type 1 diabetes. Diabetes 54, 92–99 (2005).
  Article CAS PubMed Google Scholar
• Long, S. A. et al. Defects in IL-2R signaling contribute to diminished maintenance of FOXP3 expression in CD4+CD25+ regulatory T cells of type 1 diabetic subjects. Diabetes 59, 407–415 (2010). Based on the knowledge that genes involved in the IL-2 receptor signalling pathway are associated with susceptibility to type 1 diabetes, this paper identifies a defect in IL-2 receptor signalling in CD4+CD25+ T cells from patients with type 1 diabetes and, further, links this to a lack of T Reg cell persistence in vitro.
  Article CAS PubMed Google Scholar
• Marwaha, A. K. et al. Cutting edge: Increased IL-17-secreting T cells in children with new-onset type 1 diabetes. J. Immunol. 185, 3814–3818 (2010).
  Article CAS PubMed Google Scholar
• Willcox, A. et al. Analysis of islet inflammation in human type 1 diabetes. Clin. Exp. Immunol. 155, 173–181 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Tree, T. I., Roep, B. O. & Peakman, M. A mini meta-analysis of studies on CD4+CD25+ T cells in human type 1 diabetes: report of the Immunology of Diabetes Society T Cell Workshop. Ann. NY Acad. Sci. 1079, 9–18 (2006). This paper reviews the early studies of T Reg cells in type 1 diabetes and discusses issues surrounding the assays used to assess T Reg cell function.
  Article PubMed Google Scholar
• Schneider, A. et al. The effector T cells of diabetic subjects are resistant to regulation via CD4+ FOXP3+ regulatory T cells. J. Immunol. 181, 7350–7355 (2008).
  Article CAS PubMed Google Scholar
• Lawson, J. M. et al. Increased resistance to CD4+CD25hi regulatory T cell-mediated suppression in patients with type 1 diabetes. Clin. Exp. Immunol. 154, 353–359 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• McFarland, H. F. & Martin, R. Multiple sclerosis: a complicated picture of autoimmunity. Nature Immunol. 8, 913–919 (2007).
  Article CAS Google Scholar
• Kohm, A. P. et al. Cutting edge: CD4+CD25+ regulatory T cells suppress antigen-specific autoreactive immune responses and central nervous system inflammation during active experimental autoimmune encephalomyelitis. J. Immunol. 169, 4712–4716 (2002).
  Article CAS PubMed Google Scholar
• Viglietta, V. et al. Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis. J. Exp. Med. 199, 971–979 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Putheti, P. et al. Circulating CD4+CD25+ T regulatory cells are not altered in multiple sclerosis and unaffected by disease-modulating drugs. J. Clin. Immunol. 24, 155–161 (2004).
  Article CAS PubMed Google Scholar
• Haas, J. et al. Prevalence of newly generated naive regulatory T cells (Treg) is critical for Treg suppressive function and determines Treg dysfunction in multiple sclerosis. J. Immunol. 179, 1322–1330 (2007).
  Article CAS PubMed Google Scholar
• Feger, U. et al. Increased frequency of CD4+ CD25+ regulatory T cells in the cerebrospinal fluid but not in the blood of multiple sclerosis patients. Clin. Exp. Immunol. 147, 412–418 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Michel, L. et al. Patients with relapsing-remitting multiple sclerosis have normal Treg function when cells expressing IL-7 receptor α-chain are excluded from the analysis. J. Clin. Invest. 118, 3411–3419 (2008).
  CAS PubMed PubMed Central Google Scholar
• Venken, K. et al. Natural naive CD4+CD25+CD127low regulatory T cell (Treg) development and function are disturbed in multiple sclerosis patients: recovery of memory Treg homeostasis during disease progression. J. Immunol. 180, 6411–6420 (2008).
  Article CAS PubMed Google Scholar
• Borsellino, G. et al. Expression of ectonucleotidase CD39 by Foxp3+ Treg cells: hydrolysis of extracellular ATP and immune suppression. Blood 110, 1225–1232 (2007).
  Article CAS PubMed Google Scholar
• Venken, K. et al. Compromised CD4+ CD25high regulatory T-cell function in patients with relapsing-remitting multiple sclerosis is correlated with a reduced frequency of FOXP3-positive cells and reduced FOXP3 expression at the single-cell level. Immunology 123, 79–89 (2007).
  Article CAS PubMed Google Scholar
• Kumar, M. et al. CD4+CD25+FoxP3+ T lymphocytes fail to suppress myelin basic protein-induced proliferation in patients with multiple sclerosis. J. Neuroimmunol. 180, 178–184 (2006).
  Article CAS PubMed Google Scholar
• de Andrés, C. et al. Interferon β-1a therapy enhances CD4+ regulatory T-cell function: an ex vivo and in vitro longitudinal study in relapsing-remitting multiple sclerosis. J. Neuroimmunol. 182, 204–211 (2007).
  Article CAS PubMed Google Scholar
• Oh, U. et al. Regulatory T cells are reduced during anti-CD25 antibody treatment of multiple sclerosis. Arch. Neurol. 66, 471–479 (2009).
  Article PubMed PubMed Central Google Scholar
• Haas, J. et al. Reduced suppressive effect of CD4+CD25high regulatory T cells on the T cell immune response against myelin oligodendrocyte glycoprotein in patients with multiple sclerosis. Eur. J. Immunol. 35, 3343–3352 (2005).
  Article CAS PubMed Google Scholar
• Huan, J. et al. Decreased FOXP3 levels in multiple sclerosis patients. J. Neurosci. Res. 81, 45–52 (2005).
  Article CAS PubMed Google Scholar
• Astier, A. L. et al. Alterations in CD46-mediated Tr1 regulatory T cells in patients with multiple sclerosis. J. Clin. Invest. 116, 3252–3257 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Venigalla, R. K. et al. Reduced CD4+, CD25− T cell sensitivity to the suppressive function of CD4+, CD25high, CD127−/low regulatory T cells in patients with active systemic lupus erythematosus. Arthritis Rheum. 58, 2120–2130 (2008).
  Article PubMed Google Scholar
• Vargas-Rojas, M. I. et al. Quantitative and qualitative normal regulatory T cells are not capable of inducing suppression in SLE patients due to T-cell resistance. Lupus 17, 289–294 (2008). References 60 and 61 were the first studies to clearly show effector T cell resistance in patients with autoimmune disease.
  Article CAS PubMed Google Scholar
• Gerli, R. et al. Identification of regulatory T cells in systemic lupus erythematosus. Autoimmun. Rev. 8, 426–430 (2009). An excellent review of the literature on T Reg cells and SLE.
  Article CAS PubMed Google Scholar
• Crispin, J. C., Martinez, A. & Alcocer-Varela, J. Quantification of regulatory T cells in patients with systemic lupus erythematosus. J. Autoimmun. 21, 273–276 (2003).
  Article PubMed Google Scholar
• Miyara, M. et al. Global natural regulatory T cell depletion in active systemic lupus erythematosus. J. Immunol. 175, 8392–8400 (2005).
  Article CAS PubMed Google Scholar
• Mellor-Pita, S. et al. Decrease of regulatory T cells in patients with systemic lupus erythematosus. Ann. Rheum. Dis. 65, 553–554 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Suen, J. L. et al. Altered homeostasis of CD4+ FoxP3+ regulatory T-cell subpopulations in systemic lupus erythematosus. Immunology 127, 196–205 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Lee, J. H. et al. Inverse correlation between CD4+ regulatory T-cell population and autoantibody levels in paediatric patients with systemic lupus erythematosus. Immunology 117, 280–286 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Liu, M. F. et al. Decreased CD4+CD25+ T cells in peripheral blood of patients with systemic lupus erythematosus. Scand. J. Immunol. 59, 198–202 (2004).
  Article PubMed Google Scholar
• Suarez, A. et al. Enrichment of CD4+ CD25high T cell population in patients with systemic lupus erythematosus treated with glucocorticoids. Ann. Rheum. Dis. 65, 1512–1517 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Zhang, B. et al. Reduction of forkhead box P3 levels in CD4+CD25high T cells in patients with new-onset systemic lupus erythematosus. Clin. Exp. Immunol. 153, 182–187 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Alvarado-Sanchez, B. et al. Regulatory T cells in patients with systemic lupus erythematosus. J. Autoimmun. 27, 110–118 (2006).
  Article CAS PubMed Google Scholar
• Valencia, X. et al. Deficient CD4+CD25high T regulatory cell function in patients with active systemic lupus erythematosus. J. Immunol. 178, 2579–2588 (2007).
  Article CAS PubMed Google Scholar
• Yan, B. et al. Dysfunctional CD4+, CD25+ regulatory T cells in untreated active systemic lupus erythematosus secondary to interferon-α-producing antigen-presenting cells. Arthritis Rheum. 58, 801–812 (2008).
  Article CAS PubMed Google Scholar
• Yates, J. et al. Natural regulatory T cells: number and function are normal in the majority of patients with lupus nephritis. Clin. Exp. Immunol. 153, 44–55 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Morgan, M. E. et al. CD25+ cell depletion hastens the onset of severe disease in collagen-induced arthritis. Arthritis Rheum. 48, 1452–1460 (2003).
  Article PubMed Google Scholar
• Cao, D. et al. Isolation and functional characterization of regulatory CD25brightCD4+ T cells from the target organ of patients with rheumatoid arthritis. Eur. J. Immunol. 33, 215–223 (2003).
  Article CAS PubMed Google Scholar
• Mottonen, M. et al. CD4+ CD25+ T cells with the phenotypic and functional characteristics of regulatory T cells are enriched in the synovial fluid of patients with rheumatoid arthritis. Clin. Exp. Immunol. 140, 360–367 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Lawson, C. A. et al. Early rheumatoid arthritis is associated with a deficit in the CD4+CD25high regulatory T cell population in peripheral blood. Rheumatology 45, 1210–1217 (2006).
  Article CAS PubMed Google Scholar
• Han, G. M. et al. CD4+CD25high T cell numbers are enriched in the peripheral blood of patients with rheumatoid arthritis. Cell. Immunol. 253, 92–101 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Ehrenstein, M. R. et al. Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFα therapy. J. Exp. Med. 200, 277–285 (2004). A thorough study of T Reg cell function in rheumatoid arthritis and during TNF-targeted therapy.
  Article CAS PubMed PubMed Central Google Scholar
• Flores-Borja, F. et al. Defects in CTLA-4 are associated with abnormal regulatory T cell function in rheumatoid arthritis. Proc. Natl Acad. Sci. USA 105, 19396–19401 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• van Amelsfort, J. M. et al. Proinflammatory mediator-induced reversal of CD4+, CD25+ regulatory T cell-mediated suppression in rheumatoid arthritis. Arthritis Rheum. 56, 732–742 (2007).
  Article CAS PubMed Google Scholar
• Izcue, A. & Powrie, F. Special regulatory T-cell review: regulatory T cells and the intestinal tract — patrolling the frontier. Immunology 123, 6–10 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Saruta, M. et al. Characterization of FOXP3+CD4+ regulatory T cells in Crohn's disease. Clin. Immunol. 125, 281–290 (2007).
  Article CAS PubMed Google Scholar
• Takahashi, M. et al. An inverse correlation of human peripheral blood regulatory T cell frequency with the disease activity of ulcerative colitis. Dig. Dis. Sci. 51, 677–686 (2006).
  Article PubMed Google Scholar
• Maul, J. et al. Peripheral and intestinal regulatory CD4+ CD25high T cells in inflammatory bowel disease. Gastroenterology 128, 1868–1878 (2005). This is a well-controlled study of T Reg cell numbers in IBD that is notable for its use of inflammatory controls.
  Article CAS PubMed Google Scholar
• Li, Z. et al. Reciprocal changes of Foxp3 expression in blood and intestinal mucosa in IBD patients responding to infliximab. Inflamm. Bowel Dis. 16, 1299–1310 (2010).
  Article CAS PubMed Google Scholar
• Eastaff-Leung, N. et al. Foxp3+ regulatory T cells, Th17 effector cells, and cytokine environment in inflammatory bowel disease. J. Clin. Immunol. 30, 80–89 (2010).
  Article CAS PubMed Google Scholar
• Rahman, M. K. et al. The pathogen recognition receptor NOD2 regulates human FOXP3+ T cell survival. J. Immunol. 184, 7247–7256 (2010).
  Article CAS PubMed Google Scholar
• Uhlig, H. H. et al. Characterization of Foxp3+CD4+CD25+ and IL-10-secreting CD4+CD25+ T cells during cure of colitis. J. Immunol. 177, 5852–5860 (2006).
  Article CAS PubMed Google Scholar
• Sitohy, B. et al. Basal lymphoid aggregates in ulcerative colitis colon: a site for regulatory T cell action. Clin. Exp. Immunol. 151, 326–333 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Hvas, C. L. et al. Discrete changes in circulating regulatory T cells during infliximab treatment of Crohn's disease. Autoimmunity 43, 325–333 (2010).
  Article CAS PubMed Google Scholar
• Ricciardelli, I. et al. Anti tumour necrosis-α therapy increases the number of FOXP3+ regulatory T cells in children affected by Crohn's disease. Immunology 125, 178–183 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Holmen, N. et al. Functional CD4+CD25high regulatory T cells are enriched in the colonic mucosa of patients with active ulcerative colitis and increase with disease activity. Inflamm. Bowel Dis. 12, 447–456 (2006).
  Article PubMed Google Scholar
• Yu, Q. T. et al. Expression and functional characterization of FOXP3+ CD4+ regulatory T cells in ulcerative colitis. Inflamm. Bowel Dis. 13, 191–199 (2007).
  Article PubMed Google Scholar
• Kelsen, J. et al. FoxP3+CD4+CD25+ T cells with regulatory properties can be cultured from colonic mucosa of patients with Crohn's disease. Clin. Exp. Immunol. 141, 549–557 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Makita, S. et al. Intestinal lamina propria retaining CD4+CD25+ regulatory T cells is a suppressive site of intestinal inflammation. J. Immunol. 178, 4937–4946 (2007).
  Article CAS PubMed Google Scholar
• Fantini, M. C. et al. Smad7 controls resistance of colitogenic T cells to regulatory T cell-mediated suppression. Gastroenterology 136, 1308–1316 (2009).
  Article CAS PubMed Google Scholar
• Baadsgaard, O. et al. The role of the immune system in the pathogenesis of psoriasis. J. Invest. Dermatol. 95, S32–S34 (1990).
  Article Google Scholar
• Bata-Csorgo, Z. et al. Kinetics and regulation of human keratinocyte stem cell growth in short-term primary ex vivo culture. Cooperative growth factors from psoriatic lesional T lymphocytes stimulate proliferation among psoriatic uninvolved, but not normal, stem keratinocytes. J. Clin. Invest. 95, 317–327 (1995).
  Article CAS PubMed PubMed Central Google Scholar
• Yan, K. X. et al. Foxp3+ regulatory T cells and related cytokines differentially expressed in plaque vs. guttate psoriasis vulgaris. Br. J. Dermatol. 163, 48–56 (2010).
  Article CAS PubMed Google Scholar
• Bovenschen, H. J. et al. Identification of lesional CD4+ CD25+ Foxp3+ regulatory T cells in psoriasis. Dermatology 213, 111–117 (2006).
  Article CAS PubMed Google Scholar
• Zhang, L. et al. Increased Th17 cells are accompanied by FoxP3+ Treg cell accumulation and correlated with psoriasis disease severity. Clin. Immunol. 135, 108–117 (2010).
  Article CAS PubMed Google Scholar
• Chen, L. et al. Dynamic frequency of CD4+CD25+Foxp3+ Treg cells in psoriasis vulgaris. J. Dermatol. Sci. 51, 200–203 (2008).
  Article CAS PubMed Google Scholar
• Quaglino, P. et al. Circulating CD4+CD25brightFOXP3+ T cells are up-regulated by biological therapies and correlate with the clinical response in psoriasis patients. Dermatology 219, 250–258 (2009).
  Article CAS PubMed Google Scholar
• Diluvio, L. et al. Infliximab therapy induces increased polyclonality of CD4+CD25+ regulatory T cells in psoriasis. Br. J. Dermatol. 162, 895–897 (2010).
  Article CAS PubMed Google Scholar
• Sugiyama, H. et al. Dysfunctional blood and target tissue CD4+CD25high regulatory T cells in psoriasis: mechanism underlying unrestrained pathogenic effector T cell proliferation. J. Immunol. 174, 164–173 (2005).
  Article CAS PubMed Google Scholar
• Goodman, W. A. et al. IL-6 signaling in psoriasis prevents immune suppression by regulatory T cells. J. Immunol. 183, 3170–3176 (2009). References 107 and 108 address the function of lesional T Reg cells in psoriasis and link these findings to T Reg cell- and tissue-specific mechanisms.
  Article CAS PubMed Google Scholar
• Pasare, C. & Medzhitov, R. Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells. Science 299, 1033–1036 (2003).
  Article CAS PubMed Google Scholar
• Yates, J. et al. The maintenance of human CD4+ CD25+ regulatory T cell function: IL-2, IL-4, IL-7 and IL-15 preserve optimal suppressive potency in vitro. Int. Immunol. 19, 785–799 (2007).
  Article CAS PubMed Google Scholar
• Valencia, X. et al. TNF downmodulates the function of human CD4+CD25hi T-regulatory cells. Blood 108, 253–261 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Thornton, A. M. et al. Cutting edge: IL-2 is critically required for the in vitro activation of CD4+CD25+ T cell suppressor function. J. Immunol. 172, 6519–6523 (2004).
  Article CAS PubMed Google Scholar
• King, I. L. & Segal, B. M. Cutting edge: IL-12 induces CD4+CD25− T cell activation in the presence of T regulatory cells. J. Immunol. 175, 641–645 (2005).
  Article CAS PubMed Google Scholar
• Ben Ahmed, M. et al. IL-15 renders conventional lymphocytes resistant to suppressive functions of regulatory T cells through activation of the phosphatidylinositol 3-kinase pathway. J. Immunol. 182, 6763–6770 (2009).
  Article CAS PubMed Google Scholar
• Yang, J. et al. Allograft rejection mediated by memory T cells is resistant to regulation. Proc. Natl Acad. Sci. USA 104, 19954–19959 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Takeda, I. et al. Distinct roles for the OX40–OX40 ligand interaction in regulatory and nonregulatory T cells. J. Immunol. 172, 3580–3589 (2004).
  Article CAS PubMed Google Scholar
• Choi, B. K. et al. 4-1BB-dependent inhibition of immunosuppression by activated CD4+CD25+ T cells. J. Leukoc. Biol. 75, 785–791 (2004).
  Article CAS PubMed Google Scholar
• Groux, H. et al. Interleukin-10 induces a long-term antigen-specific anergic state in human CD4+ T cells. J. Exp. Med. 184, 19–29 (1996).
  Article CAS PubMed Google Scholar
• Weiner, H. L. Induction and mechanism of action of transforming growth factor-β-secreting Th3 regulatory cells. Immunol. Rev. 182, 207–214 (2001).
  Article CAS PubMed Google Scholar
• Janson, P. C. et al. FOXP3 promoter demethylation reveals the committed Treg population in humans. PLoS ONE 3, e1612 (2008).
  Article PubMed PubMed Central CAS Google Scholar